Excellent
Excellent app !!! Way to go my friend Dr. Bakalov.
Description
Research in Hematology and Oncology has seen a remarkable growth with a significant amount of treatment advancements in recent years. Keeping up with recent literature has become more challenging. In the HemeOncBuddy app you can find the most important and practice-changing clinical trials in Hematology and Oncology.
The goal of this app is to make clinical trial information easily available for quick reference. The trial summaries are organized in a unique simplified way to provide all the pertinent information on one page. Every trial summary includes background information with inclusion criteria for the population of interest. The exclusion criteria are included if the editor deems them to be important or different from other trials. Every unique summary has information on the primary endpoints, median follow up, and the outcomes on primary endpoints.
More information on our website: https://www.hemeoncbuddy.com
Hide
Show More...
The goal of this app is to make clinical trial information easily available for quick reference. The trial summaries are organized in a unique simplified way to provide all the pertinent information on one page. Every trial summary includes background information with inclusion criteria for the population of interest. The exclusion criteria are included if the editor deems them to be important or different from other trials. Every unique summary has information on the primary endpoints, median follow up, and the outcomes on primary endpoints.
More information on our website: https://www.hemeoncbuddy.com
Screenshots
HemeOncBuddy FAQ
-
Is HemeOncBuddy free?
Yes, HemeOncBuddy is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is HemeOncBuddy legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does HemeOncBuddy cost?
HemeOncBuddy is free.
-
What is HemeOncBuddy revenue?
To get estimated revenue of HemeOncBuddy app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Pakistan yet.
Ratings History
HemeOncBuddy Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
HemeOncBuddy Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
ASTCT Practice Guidelines
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
Research To Practice
|
Unlock
|
Unlock
|
0
|
|
5 months ago | |
SITC Immunotherapy Guidelines
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
Tempus Provider
Track and view patient results
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
ASCO Guidelines
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
theMednet
Q&A from experts in medicine
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
CARTOX
Toxicity assessment tool
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
ASH Pocket Guides
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
Hem/Onc @Point of Care
Hematology & Oncology
|
Unlock
|
Unlock
|
0
|
|
4 months ago |
HemeOncBuddy Installs
Last 30 days
HemeOncBuddy Revenue
Last 30 daysHemeOncBuddy Revenue and Downloads
Gain valuable insights into HemeOncBuddy performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Veli Bakalov
- Languages
- English
- Recent release
- 3.0 (1 year ago )
- Released on
- Sep 2, 2021 (3 years ago )
- Also available in
- United States , Türkiye , Canada , Colombia , Mexico , Philippines , Peru , New Zealand , Norway , Netherlands , Nigeria , Malaysia , Portugal , Lebanon , Kazakhstan , Kuwait , South Korea , Japan , Pakistan , Poland , India , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Taiwan , Ukraine , Vietnam , South Africa , Algeria , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Switzerland , Chile , China , Czechia , Germany , Denmark , Dominican Republic , Italy , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , United Arab Emirates
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.